Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Trametinib (Primary) ; Dabrafenib
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms DEIS
- 23 Feb 2017 Status changed from active, no longer recruiting to completed.
- 10 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 13 May 2015 New trial record